| 亞洲大學 |
2014-06 |
p53 Is a Key Regulator for Osthole-Triggered
|
蔡政芳;Tsai, Cheng-Fang |
| 亞洲大學 |
2014-06 |
p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis
|
Hua, Ssu-Ming;Huang, Ssu-Ming;蔡政芳;Tsai, Cheng-Fang;Chen, Dar-Ren;Chen, Dar-Ren;Wan, Min-Ying;Wang, Min-Ying;Yeh, Wei-Lan;Yeh, Wei-Lan |
| 國家衛生研究院 |
2018-12 |
p53 is sequestered by mitochondrial chaperone Lon in the matrix to restrain apoptosis under oxidative stress
|
Sung, YJ;Lee, YL |
| 國立成功大學 |
2013-02-15 |
p53 modulates the AMPK inhibitor compound C induced apoptosis in human skin cancer cells
|
Huang, Shi-Wei; Wu, Chun-Ying; Wang, Yen-Ting; Kao, Jun-Kai; Lin, Chi-Chen; Chang, Chia-Che; Mu, Szu-Wei; Chen, Yu-Yu; Chiu, Husan-Wen; Chang, Chuan-Hsun; Liang, Shu-Mei; Chen, Yi-Ju; Huang, Jau-Ling; Shieh, Jeng-Jer |
| 國立臺灣大學 |
1998 |
P53 Mutation in Advanced Stage of Primary Myelodysplastic Syndrome
|
唐季祿; 田蕙芬; 陳耀昌; TANG, JIH-LUH; TIEN, HWEI-FANG; CHEN, YAO-CHANG |
| 臺大學術典藏 |
2021-07-03T03:36:01Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
Tang J.-L.; Tien H.-F.; Lin M.-T.; PEI-JER CHEN; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-06T03:59:03Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
JIH-LUH TANG; Tien H.-F.; Lin M.-T.; Chen P.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-26T09:08:25Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
Tang J.-L.; Tien H.-F.; Lin M.-T.; Chen P.-J.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-01-04T12:13:08Z |
P53 mutation in advanced stage of primary myelodysplastic syndrome
|
HWEI-FANG TIEN; Lin M.-T.; Tang J.-L.; Chen P.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2018-09-10T06:12:56Z |
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
|
Lunn, R.M. and Zhang, Y.-J. and Wang, L.-Y. and Chen, C.-J. and Lee, P.-H. and Lee, C.-S. and Tsai, W.-Y. and Santella, R.M.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:43:22Z |
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan
|
Lunn R.M.; Zhang Y.-J.; Wang L.-Y.; Chen C.-J.; PO-HUANG LEE; Lee C.-S.; Tsai W.-Y.; Santella R.M.; Lunn R.M.;Zhang Y.-J.;Wang L.-Y.;Chen C.-J.;Po-Huang Lee;Lee C.-S.;Tsai W.-Y.;Santella R.M. |
| 國立暨南國際大學 |
2012 |
p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
|
余長澤; Yu, CTR |
| 國立臺北護理健康大學 |
1993-11 |
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer
|
Esrig, D;Spruck, CH;Nichols, PW;Chaiwun, B;Steven, K;Groshen, S;Chen, S-C;Skinner, DG;Jones, PA;Cote, RJ |
| 國立臺灣大學 |
2004 |
P53 Overexpression and Mutation in Metaplastic Carcinoma of the Breast: Genetic Evidence for a Monoclonal Origin of Both the Carcinomatous and the Heterogeneous Sarcomatous Components
|
連晃駿; 林中梧; 毛翠蓮; 郭頌鑫; 蕭正祥; 黃俊升; LIEN, HUANG-CHUN; LIN, CHUNG-WU; MAO, TSUI-LIEN; KUO, SUNG-HSIN; HSIAO, CHENG-HSIANG; HUANG, CHIUN-SHENG |
| 國立臺灣大學 |
2004-10 |
p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien, HC; Lin, CW; Mao, TL; Kuo, SH; Hsiao, CH; Huang, CS: |
| 臺大學術典藏 |
2018-09-10T04:46:16Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien, H.-C. and Lin, C.-W. and Mao, T.-L. and Kuo, S.-H. and Hsiao, C.-H. and Huang, C.-S.; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHUNG-WU LIN; HUANG-CHUN LIEN |
| 臺大學術典藏 |
2020-03-03T03:36:54Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Chung-Wu Lin;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; CHUNG-WU LIN; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-05T05:51:25Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Huang-Chun Lien;Lin C.-W.;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; HUANG-CHUN LIEN; Lin C.-W.; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-07T06:48:26Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Tsui-Lien Mao;Kuo S.-H.;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; Lin C.-W.; TSUI-LIEN MAO; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2020-03-23T07:19:35Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Mao T.-L.;Kuo S.-H.;Hsiao C.-H.;Chiun-Sheng Huang; Lien H.-C.; Lin C.-W.; Mao T.-L.; Kuo S.-H.; Hsiao C.-H.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-05T12:32:57Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.; Lin C.-W.; TSUI-LIEN MAO; Kuo S.-H.; Hsiao C.-H.; Huang C.-S. |
| 臺大學術典藏 |
2021-02-23T08:26:44Z |
p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components
|
Lien H.-C.;Lin C.-W.;Mao T.-L.;Sung-Hsin Kuo;Hsiao C.-H.;Huang C.-S.; Lien H.-C.; Lin C.-W.; Mao T.-L.; SUNG-HSIN KUO; Hsiao C.-H.; Huang C.-S. |
| 國立臺灣大學 |
2002 |
P53 Overexpression Predicts Poor Chemosensitivity to High-Dose 5- Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Colorectal Cancers after Palliative Bowel Resection
|
梁金銅; 黃國晉; 鄭永銘; 許輝吉; 鄭安理; 徐志宏; 葉坤輝; 王世名; 張金堅; LIANG, JIN-TUNG; HUANG, KUO-CHIN; JENG, YUNG-MING; HSU, HEY-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; WANG, SHIH-MING; CHANG, KING-JEN |
| 臺大學術典藏 |
2021-01-14T03:09:20Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; KUO-CHIN HUANG; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2022-08-12T06:28:26Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; KING-JEN CHANG |
